
VIA Israel Pharmacy
Researchers from Charité – Universitätsmedizin Berlin and the Zuse Institute Berlin have developed a new generation of pain medications.
The researchers used computer simulations to develop new opioids that will only work at sites affected by injury or inflammation. These drugs can prevent the occurrence of brain- and gut-related side effects typically associated with conventional opioids and have been shown to be successful in preclinical studies. Results from this research have been published in Pain* and Scientific Reports**.
Opioids are a class of drugs with powerful pain-relieving properties. They are mainly used to treat the pain associated with tissue damage and inflammation, such as that caused by surgery or cancer. Common side effects associated with their use include drowsiness, nausea, constipation, dependency and, in some cases, respiratory arrest. The research team, which is led by Prof. Dr. Christoph Stein of the Department of Anesthesiology and Surgical Intensive Care Medicine on Campus Benjamin Franklin, are hoping to develop new types of pain medications which will work without producing dangerous side effects. Collaborating with PD Dr. Marcus Weber of the Zuse Institute Berlin, the researchers used computer simulations to develop two new opioids. In both cases, the researchers used fentanyl as the starting molecule.
The researchers hypothesized that tissues which are damaged or inflamed show stronger interaction between ‘opioid agonists’ – the substances that elicit the pain-relieving effect – and the opioid receptors they bind to. Their computer simulations suggested that this is due to an increased concentration of protons in inflamed tissues, which leads to lower pH values than in healthy tissues, resulting in acidic conditions. Opioid molecules need to undergo protonation before they can bind to and activate opioid receptors. The researchers used this knowledge to design two drugs that would only exist in their protonated state in the presence of inflammation. This restricts opioid receptor activation to sites of tissue damage or inflammation, rather than receptors in the brain or gut.
“Our innovative design method provides a robust basis for a new generation of pain medications,” reports Prof. Stein. He adds: “These drugs could help us both to avoid the dangerous side effects of conventional opioids and to reduce complications. They would also help us stem the opioid crisis, a problem that is particularly evident in the United States.”
The researchers hope to further develop these newly-designed drugs in order to make them available to patients. They also plan to enhance their understanding of the molecular processes underlying the complex interactions seen in inflamed tissues, in the hope that they may be able to support opioid optimization through the insights they gain. Ideally, their insights will also be beneficial for other drugs, such as those used to treat high blood pressure.
Learn more: Charité researchers lay the groundwork for drugs with fewer side effects
The Latest on: Pain medications
[google_news title=”” keyword=”pain medications” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Pain medications
- NYC urologist Darius Paduch accused of sexual abuse wanted to ‘inflict pain’ on patients, got them hooked on opioids: suiton September 28, 2023 at 8:55 pm
A urologist — who is accused of sexually assaulting patients — performed unnecessary surgical procedures without anesthesia so he could “inflict pain,” a suit claims.
- Zador: Medication is not the only way to manage chronic painon September 28, 2023 at 5:17 pm
But the world of pain management extends beyond medical settings as well. In fact, nonpharmacological pain management is an important component of navigating chronic pain. As individualized as the ...
- Will anti-inflammatory medications affect the efficacy of vaccines? Dr. Mallika Marshall answers your questionson September 28, 2023 at 2:34 pm
Larry writes, "I took naproxen a few hours before I got my updated Covid booster and flu shot. Will the anti-inflammatory action of the naproxen affect the efficacy of the vaccines?" ...
- Professional FAQs: Does a knee brace help in relieving sciatica pain?on September 28, 2023 at 2:28 pm
Expert opinion from Shaheen Bin Hameed Doctor of Medicine (MBBS) · 9 years of experience · India Sciatica pain is caused by irritation of sciatic nerve, commonly due to disc herniation or other causes ...
- Empowering minoritized patients with chronic back and other musculoskeletal pain to receive the care they needon September 28, 2023 at 12:24 pm
A new study led by a U.S. Department of Veterans Affairs, Regenstrief Institute and Indiana University School of Medicine researcher focuses on empowering minoritized patients with chronic back and ...
- Nurse accused of stealing medication from 50+ maternity patientson September 28, 2023 at 9:51 am
Former Iowa nurse Christina Olson is accused of stealing pain medication from over 50 maternity patients and replacing it with saline.
- Chest Pain: 11 Causes, Symptoms And Treatment Optionson September 28, 2023 at 9:38 am
Read on to learn more about chest pain, including its potential causes, symptoms and available treatment options. Chest pain, which may occur anywhere between the neck and upper abdomen, can manifest ...
- New study provides evidence for more effective brain-based treatment of chronic back painon September 28, 2023 at 8:00 am
A new study in JAMA Network Open may provide key answers to how to help people experiencing chronic back pain.
- Chronic Back Pain May Be Eased With This Type of Talk Therapyon September 28, 2023 at 7:36 am
New research shows that people with chronic back pain who underwent pain reprocessing therapy (PRT) were more likely after treatment to see their pain as stemming from their mind or brain.
via Bing News